Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
James A Simon & Michael C Snabes. (2007) Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen. Expert Opinion on Investigational Drugs 16:12, pages 2005-2020.
Read now
Read now
Amos Pines, David W. Sturdee, Alastair H. MacLennan, Hermann P. G. Schneider, Henry Burger & Anna Fenton. (2007) The heart of the WHI study: time for hormone therapy policies to be revised. Climacteric 10:4, pages 267-269.
Read now
Read now
Articles from other publishers (4)
Supanimit Teekachunhatean, Natnita Mattawanon & Surapan Khunamornpong. (2015) Short-Term Isoflavone Intervention in the Treatment of Severe Vasomotor Symptoms after Surgical Menopause: A Case Report and Literature Review. Case Reports in Obstetrics and Gynecology 2015, pages 1-7.
Crossref
Crossref
Youn-Jee ChungMee-Ran KimHye-Won JeongByung Koo YoonByung Suk LeeByung Moon KangHoon ChoiHyoung Moo ParkJung Gu Kim. (2012) Changing Korean Menopausal Women's Awareness on Hormone Therapy: 7-years after Women's Health Initiative Study. The Journal of Korean Society of Menopause 18:2, pages 94.
Crossref
Crossref
Madge R Vickers, Jeannett Martin & Tom W Meade. (2007) The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial. BMC Women's Health 7:1.
Crossref
Crossref
Loretta P. MayerCheryl A. DyerRebecca L. EastgardPatricia B. HoyerCarole L. Banka. (2005) Atherosclerotic Lesion Development in a Novel Ovary-Intact Mouse Model of Perimenopause. Arteriosclerosis, Thrombosis, and Vascular Biology 25:9, pages 1910-1916.
Crossref
Crossref